CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Cardiol Therapeutics Inc.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026
$1.10+0.00 (0.00%)
Close on Oct 19, 2026
Community
Notes and questions about Cardiol Therapeutics from other investors
No posts about CRDL yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.